Midlife adiposity and the future risk of Parkinson's disease

Neurology

Volumn 59, Issue 7, 2002, Pages 1051-1057

  Abbott, Robert D ^a   Ross, G W ^a   White, L R ^a   Nelson, J S ^a   Masaki, K H ^a   Tanner, C M ^a   Curb, J D ^a   Blanchette, P L ^a   Popper, J S ^a   Petrovitch, H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CALORIC INTAKE; CIGARETTE SMOKING; COFFEE; CONTROLLED STUDY; FAT INTAKE; FOLLOW UP; HUMAN; INCIDENCE; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; OBESITY; ONSET AGE; PARKINSON DISEASE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; SCAPULA; SKINFOLD THICKNESS; TRICEPS BRACHII MUSCLE; UNITED STATES;

EID: 0037044236     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.7.1051     Document Type: Article

References (42)

1. Lang AE, Lozano AM. Parkinson's disease: First of two parts. N Engl J Med 1998;339:1044-1053.
2. Korczyn AD. Autonomic nervous system dysfunction in Parkinson's disease. In: Calne DB, Comi G, Crippa D, Horawski R, Trabucchi M, eds. Parkinsonism and aging. New York: Raven Press, 1989:211-219.
3. Korczyn AD. Autonomic nervous system screening in patients with early Parkinson's disease. In: Przuntek H, Riederer P, eds. Early diagnosis and preventive therapy in Parkinson's disease. Vienna: Springer-Verlag, 1989:41-48.
4. Singer C, Weiner WJ, Sanchez-Ramos JR. Autonomic dysfunction in men with Parkinson's disease. Eur Neurol 1992;32:134-140.
5. Korczyn AD. Autonomic nervous system disturbances in Parkinson's disease. Adv Neurol 1990;53:463-468.
6. Martignoni E, Pacchetti C, Codi L, Micieli G, Nappi G. Autonomic disorders in Parkinson's disease. J Neural Trans 1995;45(suppl):11-19.
7. Linden D, Diehl RR, Berlit P. Sympathetic cardiovascular dysfunction in long-standing Parkinson's disease. Clin Autonomic Res 1997;7:311-314.
8. Kelly JP. Principles of the function and anatomical organization of the nervous system. In: Kandel ER, Schwartz JH, ed. Principles of neural sciences. 2nd ed. New York: Elsevier, 1985:211-221.
9. Wang GJ, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet 2001;357:354-357.
10. Kagan A, Harris BR, Winkelstein W Jr, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary, and biochemical characteristics. J Chron Dis 1974;27:345-364.
11. Heilbrun LK, Kagan A, Nomura A, Wasnich RD. The origins of epidemiologic studies of heart disease, cancer and osteoporosis among Hawaii Japanese. Hawaii Med J 1985;44:294-296.
12. Yano K, Reed DM, McGee DL. Ten-year incidence of coronary heart disease in the Honolulu Heart Program: Relationship to biologic and lifestyle characteristics. Am J Epidemiol 1984;119:653-666.
13. Ross GW, Abbott RD, Petrovitch H, et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 2000;283:2674-2679.
14. Grandinetti A, Morens D, Reed D, MacEachern D. Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol 1994;139:1129-1138.
15. McGee D, Rhoads G, Hankin J, Yano K, Tillotson J. Within-person variability of nutrient intake in a group of Hawaiian men of Japanese ancestry. Am J Clin Nutr 1982;36:657-663.
16. Kannel WB, Sorlie PD. Some health benefits of physical activity: the Framingham Study. Arch Int Med 1979;139:857-861.
17. Garcia-Palmieri MR, Costas R, Cruz-Vidal M, et al. Increased physical activity: a protective factor against heart attack in Puerto Rico. Am J Cardiol 1982;50:749-755.
18. Donahue RP, Abbott RD, Reed DM, Yano K. Physical activity and coronary heart disease in middle-aged and elderly men: the Honolulu Heart Program. Am J Public Health 1988;78:683-685.
19. Abbott RD, Rodriguez BL, Burchfiel CM, Curb JD. Physical activity in older middle-aged men and reduced risk of stroke: the Honolulu Heart Program. Am J Epidemiol 1994;139:881-893.
20. Ward CD, Gibb WR. Research diagnostic criteria for Parkinson's disease. Adv Neurol 1990;53:245-249.
21. Morens DM, Davis JW, Grandinetti A, Ross GW, Popper JS, White LR. Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle-aged men. Neurology 1996;46:1044-1050.
22. Lane PW, Nelder JA. Analysis of covariance and standardization as instances of prediction. Biometrics 1982;38:613-621.
23. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-202.
24. Beyer PL, Palarino MY, Michalek D, Busenbark K, Koller WC. Weight change and body composition in patients with Parkinson's disease. J Am Diet Assoc 1995;95:979-983.
25. Durrieu GL, Lau ME, Rascol O, Senard JM, Rascol A, Montastruc JL. Parkinson's disease and weight loss: a study with anthropometric and nutritional assessment. Clin Autonomic Res 1992;2:153-157.
26. Fearnly JM, Lees AJ. Aging and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283-2301.
27. Moorish P, Sawle G, Brooks D. An [18F] dopa-PET and clinical study of the rate of progression in Parkinson's disease. Brain 1996;119:585-591.
28. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
29. Kley HK, Edelmann P, Kruskemper HL. Relationship of plasma sex hormones to different parameters of obesity in male subjects. Metabolism 1980;29:1041-1045.
30. Szymczak J, Milewicz A, Thijssen JHH, Blankenstein MA, Daroszewski J. Concentration of sex steroids in adipose tissue after menopause. Steroids 1998;63:319-321.
31. Benedetti MD, Maraganore DM, Bower JH, et al. Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study. Mov Disord 2001;16:830-837.
32. Session DR, Pearlstone MM, Jewelewicz R, Kelly AC. Estrogens and Parkinson's disease. Med Hypotheses 1994;42:280-282.
33. Zhang Z-X, Roman GC. Worldwide occurrence of Parkinson's disease: an updated review. Neuroepidemiology 1993;12:195-208.
34. Abbott RD, White LR, Ross GW, et al. Height as a marker of childhood development and late-life cognitive function: the Honolulu-Asia Aging Study. Pediatrics 1998;102:602-609.
35. Sriram K, Benkovic SA, Millecchia L, Miller DB, O'Callaghan JP. Leptin-deficient (ob/ob) condition exacerbates neurodegeneration. Neuroscience (in press).
36. Baptista T. Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiatr Scand 1999;100:3-16.
37. Towell A, Muscat R, Willner P. Behavioral microanalysis of the role of dopamine in amphetamine anorexia. Pharmacol Biochem Behav 1988;30:641-648.
38. Vardi J, Oberman Z, Rabey I, Streifier M, Ayalon D, Herzberg M. Weight loss in patients treated long-term with levodopa: metabolic aspects. J Neurol Sci 1976;30:33-40.
39. Johnson CC, Gorell JM, Rybicki BA, Sanders K, Peterson EL. Adult nutrient intake as a risk factor for Parkinson's disease. Int J Epidemiol 1999;28:1102-1109.
40. Logroscino G, Marder K, Cote L, Tang MX, Shea S, Mayeux R. Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study. Ann Neurol 1996;39:89-94.
41. Trabulsi J, Schoeller DA. Evaluation of dietary assessment instruments against doubly labeled water, a biomarker of habitual energy intake. Am J Physiol Endocrinol Metab 2001;281:E891-E899.
42. Schoeller DA. How accurate is self-reported dietary energy intake? Nutr Rev 1990;48:373-379.